Stock Update (NASDAQ:ILMN): Illumina, Inc. Expands World’s Largest Genomics Analysis Platform and Adds to Open Source Initiative

Illumina, Inc. (NASDAQ:ILMN) announced several new additions to BaseSpace—the world’s largest and most comprehensive cloud computing environment—with the launch of BaseSpace Professional and Enterprise Editions, fully integrated Laboratory Information Management System (LIMS) solutions and advanced infrastructure upgrades.

“BaseSpace is continuing to show phenomenal growth with more than 75 percent year-over-year growth in new users and more than 900 percent year-over-year growth in app usage,” said Sanjay Chikarmane, Senior Vice President and General Manager of Illumina’s Enterprise Informatics. “The new Professional and Enterprise packages and infrastructure upgrades will provide the industry’s broadest, most advanced genomics analysis platform. Customers will have the speed and flexibility to manage their sequencing workflow on the cloud, reducing infrastructure cost, while accelerating basic and translational research, eventually leading to improved clinical care.”

BaseSpace is the only genomics platform that integrates sample set-up, instrument and sequencing run monitoring along with storage, analysis and sharing of large volumes of genomic data. The analysis platform is currently processing data from more than 4,000 sequencing systems worldwide, including Illumina’s population-scale sequencing system, HiSeq X™ Ten, and providing push-button analytics with over 60 apps to more than 30,000 registered users.

Genomic researchers will be able to select from advanced services that are optimized to enhance the user experience and improve efficiency in sequencing labs. BaseSpace Professional will provide multi-user access and automated app launch. BaseSpace Enterprise adds greater security and convenience through individual domains, multiple-users and groups, and single sign-on. The Enterprise edition will also have optional integration with LIMS solutions from GenoLogics, which was acquired by Illumina in August 2015, leading to improved efficiency and productivity in laboratories with high throughput.

“The integration of the leading cloud-based genomics laboratory information management system, Clarity LIMS, with the leading cloud-based analysis and storage platform, BaseSpace is a natural fit,” said Michael Ball, Vice President of GenoLogics at Illumina. “Bringing the two together provides a seamless sample to answer solution for customers.”

“We’ve been impressed with the flexibility of BaseSpace to handle data from all of the Illumina platforms, including the HiSeq X system. The ability to upload, store and analyze large-scale genomic information and share it to a cloud in real time has been a tremendous benefit to our operation,” said Shawn Levy, PhD., Director of the high-volume Genomic Services Laboratory at the HudsonAlpha Institute for Biotechnology inHuntsville, Ala. “BaseSpace’s suite of tools, robust infrastructure, and diverse analysis features allow us to share projects and data across a broad diversity of projects from around the world.”

BaseSpace is also releasing an update for its on-premise solution, BaseSpace Onsite. BaseSpace Onsite v2.1 will support more systems from Illumina’s broad range of sequencing platforms, the MiSeq®, NextSeq® and HiSeq 2500/3000/4000. The new release offers more onboard informatics analysis support with 25 apps and a recently updated version of the BaseSpace platform. BaseSpace Onsite v2.1 provides push-button informatics to users who are not yet ready to use BaseSpace in the cloud, or prefer to augment their bioinformatics team’s capability by offering self-service informatics analysis with a faster turnaround time.

While adding features to the BaseSpace platform, Illumina is also continuing its commitment to the open source community by offering its secondary analysis software under GPL v3 license, allowing users to run, share and modify the software. Currently, genomics software that are available under the license agreement include the Isaac Aligner and the Manta Structural variant caller. Other genomics analysis tools such as the Starling small variant caller, Strelka somatic variant caller, the Canvas copy number caller, and Haplotype Compare for examining variant call sets will be made available soon.

The current BaseSpace services will continue to be available free to customers with 1 TB of cloud storage. BaseSpace Professional and Enterprise will come with bioinformatics support and will be available January 2016. (Original Source)

Shares of Illumina closed yesterday at $175.82. ILMN has a 1-year high of $242.37 and a 1-year low of $145.12. The stock’s 50-day moving average is $197.17 and its 200-day moving average is $203.18.

On the ratings front, Illumina has been the subject of a number of recent research reports. In a report released yesterday, Stifel Nicolaus analyst Miroslava Minkova maintained a Buy rating on ILMN, with a price target of $235, which represents a potential upside of 33.7% from where the stock is currently trading. Separately, on September 16, BTIG’s Dane Leone reiterated a Buy rating on the stock and has a price target of $240.

According to, which ranks over 7,500 financial analysts and bloggers to gauge the performance of their past recommendations, Miroslava Minkova and Dane Leone have a total average return of 13.0% and -1.7% respectively. Minkova has a success rate of 66.7% and is ranked #1906 out of 3755 analysts, while Leone has a success rate of 31.0% and is ranked #2859.

The street is mostly Bullish on ILMN stock. Out of 9 analysts who cover the stock, 8 suggest a Buy rating and one recommends to Hold the stock. The 12-month average price target assigned to the stock is $300.00, which implies an upside of 70.6% from current levels.

Illumina Inc providessequencing-and array-based solutions for genetic analysis. Itsproducts enabled researchers to explore DNA, helping them create the first map of gene variations associated with health, disease, and drug response.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts